| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |